Ribomic Inc. (TYO:4591)

Ribomic Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-1,017	-1,023	-1,651	-1,683	-1,185
Depreciation & Amortization	-	10	-	15	26
Loss (Gain) From Sale of Assets	2	40	3	48	-
Other Operating Activities	3	1	-	2	1
Change in Accounts Receivable	-	-	-	-	108
Change in Inventory	-1	-	-	-	3
Change in Accounts Payable	14	-53	-35	112	19
Change in Other Net Operating Assets	3	93	-25	7	-121
Operating Cash Flow	-996	-932	-1,708	-1,499	-1,149
Capital Expenditures	-32	-22	-23	-10	-1
Investment in Securities	100	200	300	700	-1,699
Other Investing Activities	-1	-1	-1	-1	1
Investing Cash Flow	67	177	276	689	-1,699
Issuance of Common Stock	667	27	1,332	354	4,988
Other Financing Activities	-	-	1	-	-
Financing Cash Flow	667	27	1,333	354	4,988
Foreign Exchange Rate Adjustments	-	2	21	18	-1
Miscellaneous Cash Flow Adjustments	-	1	2	2	-1
Net Cash Flow	-262	-725	-76	-436	2,138
Free Cash Flow	-1,028	-954	-1,731	-1,509	-1,150
Free Cash Flow Margin	-51400.00%	-	-2663.08%	-1886.25%	-1263.74%
Free Cash Flow Per Share	-25.43	-26.73	-55.64	-53.70	-44.73
Cash Income Tax Paid	1	1	1	1	1
Levered Free Cash Flow	-704.25	-643.5	-1,211	-939.13	-759
Unlevered Free Cash Flow	-704.25	-643.5	-1,211	-939.13	-759
Change in Net Working Capital	16	-66	71	-149	9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.